Latest stories on TLX
TLX591-Tx ProstACT SELECT Study Published in Cancers Journal | TLX Stock News
StockTitan67 · bullishproduct/pr
Telix Pharmaceuticals reports Q2 results; updates FY2026 outlook
Seeking Alpha68 · bullishearnings
Why is Telix Pharmaceuticals stock climbing today?
Investing.com Markets50 · neutralgeneral
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
Business Insider67 · bullishearnings
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress | TLX Stock News
StockTitan67 · bullishearnings
Telix Doses First Patient in Phase 3 LUTEON Trial of TLX250-Tx for Renal Cancer | TLX Stock News
StockTitan63 · neutralproduct/pr
FDA Alignment to Advance ProstACT Global Phase 3 Trial | TLX Stock News
StockTitan63 · neutralproduct/pr
Telix Pharmaceuticals Limited (TLX) Discusses Neurologic Oncology Portfolio and Advances in Therapeutic and Diagnostic Agents Transcript
Seeking Alpha56 · neutralproduct/pr
Telix Pharmaceuticals (TLX), United Imaging Healthcare Form Strategic Theranostics Research Partnership
Yahoo Finance63 · neutralproduct/pr
Telix Pharmaceuticals Limited (TLX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
Seeking Alpha50 · neutralgeneral
Telix and United Imaging Announce Strategic Theranostics Collaboration | TLX Stock News
StockTitan63 · neutralproduct/pr
ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026 | TLX Stock News
StockTitan63 · neutralproduct/pr
Telix Grants Share Appreciation Rights to Director Marie McDonald
TipRanks50 · neutralgeneral
Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences | TLX Stock News
StockTitan55 · neutralgeneral
Telix Pharmaceuticals: PSMA Radiopharmaceutical Player Is Revving Up
Seeking Alpha67 · bullishproduct/pr